Ibuprofen and COVID-19 disease: separating the myths from facts
Frideriki Poutoglidou, Athanasios Saitis, Dimitrios Kouvelas
Abstract
: The studies that have been performed so far demonstrate no association between ibuprofen use and increased mortality rates or an increased risk for respiratory support. Accordingly, we recommend ibuprofen to be used for managing COVID-19 symptoms.
Topics & Concepts
IbuprofenMedicineCoronavirus disease 2019 (COVID-19)CoronavirusDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakSpeculationIntensive care medicinePharmacologyVirologyInfectious disease (medical specialty)Internal medicineOutbreakBusinessFinanceCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsCancer, Stress, Anesthesia, and Immune Response